Product Details for NDA 017407
CATAPRES (CLONIDINE HYDROCHLORIDE)
0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CLONIDINE HYDROCHLORIDE
Proprietary Name: CATAPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017407
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status: Discontinued
Patent and Exclusivity Information
CATAPRES (CLONIDINE HYDROCHLORIDE)
Proprietary Name: CATAPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017407
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status: Discontinued
Patent and Exclusivity Information
0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CLONIDINE HYDROCHLORIDE
Proprietary Name: CATAPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017407
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status: Discontinued
Patent and Exclusivity Information
CATAPRES (CLONIDINE HYDROCHLORIDE)
Proprietary Name: CATAPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017407
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status: Discontinued
Patent and Exclusivity Information
0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CLONIDINE HYDROCHLORIDE
Proprietary Name: CATAPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017407
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CATAPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017407
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status: Discontinued
Patent and Exclusivity Information